Astex Pharmaceuticals Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 138

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 9

  • Investments
  • 5

Astex Pharmaceuticals General Information

Description

Manufacturer of novel small molecule therapeutics products designed to treat cancer and diseases of the central nervous system. The company offers small molecule therapeutics through its proprietary oncology product portfolio and multiple drugs in mid-late stage clinical development and develops novel targeted therapeutics for defined neuro-degenerative disease populations enabling patients with treatment of disease of the central nervous system.

Contact Information

Website
www.astx.com
Formerly Known As
Astex, Supergen Inc
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 436 Cambridge Science Park
  • Cambridge CB4 0QA
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 436 Cambridge Science Park
  • Cambridge CB4 0QA
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Astex Pharmaceuticals‘s full profile, request access.

Request a free trial

Astex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of novel small molecule therapeutics products designed to treat cancer and diseases of the central nervous
Drug Discovery
Cambridge, United Kingdom
138 As of 2023

Sacramento, CA
 

Coral Gables, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Astex Pharmaceuticals Competitors (83)

One of Astex Pharmaceuticals’s 83 competitors is Tricida, a Formerly VC-backed company based in Sacramento, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tricida Formerly VC-backed Sacramento, CA
Catalyst Pharmaceuticals Corporate Backed or Acquired Coral Gables, FL
Voyager Therapeutics Formerly VC-backed Lexington, MA
Celldex Formerly VC-backed Hampton, NJ
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 83 competitors. Get the full list »

Astex Pharmaceuticals Patents

Astex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023076302-A1 Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene compound Inactive 26-Oct-2021
AU-2022355189-A1 Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator Active 30-Sep-2021
AU-2022355189-B2 Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator Active 30-Sep-2021
EP-4408417-A1 Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator Inactive 30-Sep-2021
EP-4408417-A4 Combinatory therapy for cancer using biphenyl compound and immune checkpoint molecule regulator Inactive 30-Sep-2021 A61K31/40
To view Astex Pharmaceuticals’s complete patent history, request access »

Astex Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Astex Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Astex Pharmaceuticals‘s full profile, request access.

Request a free trial

Astex Pharmaceuticals Investments & Acquisitions (5)

Astex Pharmaceuticals’s most recent deal was a Early Stage VC with Tolero Pharmaceuticals for . The deal was made on 27-Jul-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tolero Pharmaceuticals 27-Jul-2012 Early Stage VC Drug Discovery
Astex Therapeutics 20-Jul-2011 Merger/Acquisition Drug Discovery
Montigen Pharmaceuticals 04-Apr-2006 Merger/Acquisition Drug Discovery
MetaGen Pharmaceuticals 31-Oct-2003 Merger/Acquisition Biotechnology
Quark Pharmaceuticals 30-May-1997 Later Stage VC Drug Discovery
To view Astex Pharmaceuticals’s complete investments and acquisitions history, request access »

Astex Pharmaceuticals Exits (2)

Astex Pharmaceuticals’s most recent exit was on 27-Jul-2012 from Tolero Pharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Tolero Pharmaceuticals 27-Jul-2012 Completed
Quark Pharmaceuticals 30-May-1997 Later Stage VC Completed
  • 2 buyers
To view Astex Pharmaceuticals’s complete exits history, request access »

Astex Pharmaceuticals FAQs

  • When was Astex Pharmaceuticals founded?

    Astex Pharmaceuticals was founded in 1999.

  • Where is Astex Pharmaceuticals headquartered?

    Astex Pharmaceuticals is headquartered in Cambridge, United Kingdom.

  • What is the size of Astex Pharmaceuticals?

    Astex Pharmaceuticals has 138 total employees.

  • What industry is Astex Pharmaceuticals in?

    Astex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Astex Pharmaceuticals a private or public company?

    Astex Pharmaceuticals is a Private company.

  • What is the current valuation of Astex Pharmaceuticals?

    The current valuation of Astex Pharmaceuticals is .

  • What is Astex Pharmaceuticals’s current revenue?

    The current revenue for Astex Pharmaceuticals is .

  • How much funding has Astex Pharmaceuticals raised over time?

    Astex Pharmaceuticals has raised $118M.

  • Who are Astex Pharmaceuticals’s investors?

    Abingworth, Cambridge Enterprise Ventures, Clarke Capital Partners, Gimv, and Industry Ventures are 5 of 9 investors who have invested in Astex Pharmaceuticals.

  • Who are Astex Pharmaceuticals’s competitors?

    Tricida, Catalyst Pharmaceuticals, Voyager Therapeutics, Celldex, and ACADIA Pharmaceuticals are some of the 83 competitors of Astex Pharmaceuticals.

  • When was Astex Pharmaceuticals acquired?

    Astex Pharmaceuticals was acquired on 11-Oct-2013.

  • Who acquired Astex Pharmaceuticals?

    Astex Pharmaceuticals was acquired by Otsuka Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process